208 related articles for article (PubMed ID: 20161707)
1. Lymphoid hyperplasia and lymphoma in transgenic mice expressing the small non-coding RNA, EBER1 of Epstein-Barr virus.
Repellin CE; Tsimbouri PM; Philbey AW; Wilson JB
PLoS One; 2010 Feb; 5(2):e9092. PubMed ID: 20161707
[TBL] [Abstract][Full Text] [Related]
2. The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis.
Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Bauml G; Rucker O; Schwarzmann F; Wolf H; Minarovits J
Med Sci Monit; 2003 Jan; 9(1):HY1-9. PubMed ID: 12552250
[TBL] [Abstract][Full Text] [Related]
3. Proteomics and Transcriptomics of BJAB Cells Expressing the Epstein-Barr Virus Noncoding RNAs EBER1 and EBER2.
Pimienta G; Fok V; Haslip M; Nagy M; Takyar S; Steitz JA
PLoS One; 2015; 10(6):e0124638. PubMed ID: 26121143
[TBL] [Abstract][Full Text] [Related]
4. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
Wang J; Boxer LM
J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
[TBL] [Abstract][Full Text] [Related]
6. A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis.
Berg T; Thoene S; Yap D; Wee T; Schoeler N; Rosten P; Lim E; Bilenky M; Mungall AJ; Oellerich T; Lee S; Lai CK; Umlandt P; Salmi A; Chang H; Yue L; Lai D; Cheng SW; Morin RD; Hirst M; Serve H; Marra MA; Morin GB; Gascoyne RD; Aparicio SA; Humphries RK
Blood; 2014 Jun; 123(25):3914-24. PubMed ID: 24802772
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors.
Owen TJ; O'Neil JD; Dawson CW; Hu C; Chen X; Yao Y; Wood VH; Mitchell LE; White RJ; Young LS; Arrand JR
Mol Cancer; 2010 Sep; 9():241. PubMed ID: 20843307
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus nuclear antigen-1 and Myc cooperate in lymphomagenesis.
Drotar ME; Silva S; Barone E; Campbell D; Tsimbouri P; Jurvansu J; Bhatia P; Klein G; Wilson JB
Int J Cancer; 2003 Sep; 106(3):388-95. PubMed ID: 12845679
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma.
Cen O; Longnecker R
Mol Cancer Ther; 2011 Apr; 10(4):679-86. PubMed ID: 21282357
[TBL] [Abstract][Full Text] [Related]
10. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
Niedobitek G; Agathanggelou A; Rowe M; Jones EL; Jones DB; Turyaguma P; Oryema J; Wright DH; Young LS
Blood; 1995 Jul; 86(2):659-65. PubMed ID: 7605996
[TBL] [Abstract][Full Text] [Related]
12. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
13. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
Rooney C; Howe JG; Speck SH; Miller G
J Virol; 1989 Apr; 63(4):1531-9. PubMed ID: 2538644
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus (EBV) genomes and c-myc oncogene in oral Burkitt's lymphomas.
Syrjänen S; Kallio P; Sainio P; Fuju C; Syrjänen K
Scand J Dent Res; 1992 Jun; 100(3):176-80. PubMed ID: 1321486
[TBL] [Abstract][Full Text] [Related]
15. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.
Yan Y; Park SS; Janz S; Eckhardt LA
Genes Chromosomes Cancer; 2007 Oct; 46(10):950-9. PubMed ID: 17639584
[TBL] [Abstract][Full Text] [Related]
16. Consideration of Epstein-Barr Virus-Encoded Noncoding RNAs EBER1 and EBER2 as a Functional Backup of Viral Oncoprotein Latent Membrane Protein 1.
Herbert KM; Pimienta G
mBio; 2016 Jan; 7(1):e01926-15. PubMed ID: 26787829
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma.
Fish K; Chen J; Longnecker R
Blood; 2014 Jan; 123(4):530-40. PubMed ID: 24174629
[TBL] [Abstract][Full Text] [Related]
18. Increased number of Epstein-Barr virus latently infected B-cells in T-cell non-Hodgkin's lymphoma tissues.
Hojo I; Takanashi M; Hirai K; Mori S
Arch Virol; 1995; 140(8):1419-26. PubMed ID: 7661694
[TBL] [Abstract][Full Text] [Related]
19. Antagonistic effects of c-myc and Epstein-Barr virus latent genes on the phenotype of human B cells.
Pajic A; Staege MS; Dudziak D; Schuhmacher M; Spitkovsky D; Eissner G; Brielmeier M; Polack A; Bornkamm GW
Int J Cancer; 2001 Sep; 93(6):810-6. PubMed ID: 11519042
[TBL] [Abstract][Full Text] [Related]
20. Expression of EBV encoded viral RNA 1, 2 and anti-inflammatory cytokine (interleukin-10) in FFPE lymphoma specimens: a preliminary study for diagnostic implication in Pakistan.
Sheikh TI; Qadri I
Diagn Pathol; 2011 Jul; 6():70. PubMed ID: 21791113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]